Jupiter Neurosciences to present at Market Movers Investor Summit on May 5, 2026

Jupiter Neurosciences, a clinical-stage pharmaceutical company developing a resveratrol-based platform called JOTROL™, will present at the Market Movers Investor Summit on May 5, 2026, at the historic Bank of New York. The event gathers executives, fund managers, and investors for high-level discussions and networking. Jupiter's CEO Christer Rosén will discuss the company's pipeline targeting CNS disorders like Parkinson's and Alzheimer's, as well as its consumer longevity product line. This presentation offers investors insight into Jupiter's innovative approach to neuroinflammation and healthy aging therapies.